Chronic Hepatitis B clinical trials

Explore recruiting chronic hepatitis b clinical trials.

Recruiting chronic hepatitis b studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Hepatitis B trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pomalidomide in people with chronic hepatitis B virus (HBV) infection: Safety and immune-enhancing effects (The PIPPI Study)

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104 (HEB-PEP)

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

HepBTer: From fungus to virus, a phase 2a clinical trial investigating the safety and efficacy of terbinafine in chronic hepatitis B patients

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase II clinical trial to evaluate the safety, efficacy, and pharmacokinetics of RBD1016 injection in participants with chronic hepatitis B

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Hepatitis B immunoglobulins to induce HBsAg clearance in patients with chronic hepatitis B (HBIG for cure)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Platform Study Evaluating the Efficacy and Safety of Investigational Therapies in Participants with Chronic Hepatitis B Infection (PREVAIL)

France, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Hepatitis B trials by city

Chronic Hepatitis B in Toronto Chronic Hepatitis B in Vancouver Chronic Hepatitis B in Montreal Chronic Hepatitis B in Calgary Chronic Hepatitis B in Edmonton Chronic Hepatitis B in Ottawa Chronic Hepatitis B in Winnipeg Chronic Hepatitis B in Quebec City Chronic Hepatitis B in Hamilton Chronic Hepatitis B in Kitchener Chronic Hepatitis B in London Chronic Hepatitis B in Halifax Chronic Hepatitis B in New York Chronic Hepatitis B in Los Angeles Chronic Hepatitis B in Chicago Chronic Hepatitis B in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease